{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:46:58Z","timestamp":1776905218524,"version":"3.51.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,22]]},"DOI":"10.7759\/cureus.107546","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:22Z","timestamp":1776902422000},"source":"Crossref","is-referenced-by-count":0,"title":["Complete Radiotherapy Response of Chemoresistant Para-Aortic Lymph Node Metastases in an Endometrial Cancer Patient Meeting the Amsterdam II Criteria for Lynch Syndrome"],"prefix":"10.7759","author":[{"given":"Isao","family":"Otsuka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazufusa","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003263","article-title":"The proportion of endometrial tumours associated with Lynch syndrome (PETALS): a prospective cross-sectional study","volume":"17","author":"Ryan NA","year":"2020","unstructured":"Ryan NA, McMahon R, Tobi S, et al.. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): a prospective cross-sectional study. PLoS Med. 2020, 17:e1003263. 10.1371\/journal.pmed.1003263","journal-title":"PLoS Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2009.12.028","article-title":"Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancer","volume":"117","author":"Resnick KE","year":"2010","unstructured":"Resnick KE, Frankel WL, Morrison CD, et al.. Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancer. Gynecol Oncol. 2010, 117:234-8. 10.1016\/j.ygyno.2009.12.028","journal-title":"Gynecol Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/PO.18.00085","article-title":"Repeated abscopal effect with radiotherapy and programmed death 1 blockade in mismatch repair-deficient endometrial cancer","volume":"2","author":"Oh MS","year":"2018","unstructured":"Oh MS, Chae YK. Repeated abscopal effect with radiotherapy and programmed death 1 blockade in mismatch repair-deficient endometrial cancer. JCO Precis Oncol. 2018, 2:1-6. 10.1200\/PO.18.00085","journal-title":"JCO Precis Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2023.01.025","article-title":"Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer","volume":"170","author":"Jamieson A","year":"2023","unstructured":"Jamieson A, Huvila J, Leung S, et al.. Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer. Gynecol Oncol. 2023, 170:282-9. 10.1016\/j.ygyno.2023.01.025","journal-title":"Gynecol Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2016.11.001","article-title":"Response to chemotherapy and prognosis in metastatic colorectal cancer with DNA deficient mismatch repair","volume":"16","author":"Alex AK","year":"2017","unstructured":"Alex AK, Siqueira S, Coudry R, Santos J, Alves M, Hoff PM, Riechelmann RP. Response to chemotherapy and prognosis in metastatic colorectal cancer with DNA deficient mismatch repair. Clin Colorectal Cancer. 2017, 16:228-39. 10.1016\/j.clcc.2016.11.001","journal-title":"Clin Colorectal Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-2820","article-title":"The efficacy of radiotherapy relies upon induction of type I interferon-dependent innate and adaptive immunity","volume":"71","author":"Burnette BC","year":"2011","unstructured":"Burnette BC, Liang H, Lee Y, et al.. The efficacy of radiotherapy relies upon induction of type I interferon-dependent innate and adaptive immunity. Cancer Res. 2011, 71:2488-96. 10.1158\/0008-5472.CAN-10-2820","journal-title":"Cancer Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2019.03.097","article-title":"Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer","volume":"154","author":"Reijnen C","year":"2019","unstructured":"Reijnen C, K\u00fcsters-Vandevelde HV, Prinsen CF, et al.. Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer. Gynecol Oncol. 2019, 154:124-30. 10.1016\/j.ygyno.2019.03.097","journal-title":"Gynecol Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-020-02578-4","article-title":"Unexpected tumor response to palliative pelvic radiotherapy in mismatch repair-deficient advanced prostate cancer: a case report","volume":"14","author":"Aluisio G","year":"2020","unstructured":"Aluisio G, Mazzeo E, Lohr F, et al.. Unexpected tumor response to palliative pelvic radiotherapy in mismatch repair-deficient advanced prostate cancer: a case report. J Med Case Rep. 2020, 14:239. 10.1186\/s13256-020-02578-4","journal-title":"J Med Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00062","article-title":"Molecular classification predicts response to radiotherapy in the randomized PORTEC-1 and PORTEC-2 trials for early-stage endometrioid endometrial cancer","volume":"41","author":"Horeweg N","year":"2023","unstructured":"Horeweg N, Nout RA, J\u00fcrgenliemk-Schulz IM, et al.. Molecular classification predicts response to radiotherapy in the randomized PORTEC-1 and PORTEC-2 trials for early-stage endometrioid endometrial cancer. J Clin Oncol. 2023, 41:4369-80. 10.1200\/JCO.23.00062","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001461","article-title":"Endometrial carcinomas with a \"serous\" component in young women are enriched for DNA mismatch repair deficiency, Lynch syndrome, and POLE exonuclease domain mutations","volume":"44","author":"Conlon N","year":"2020","unstructured":"Conlon N, Da Cruz Paula A, Ashley CW, et al.. Endometrial carcinomas with a \"serous\" component in young women are enriched for DNA mismatch repair deficiency, Lynch syndrome, and POLE exonuclease domain mutations. Am J Surg Pathol. 2020, 44:641-8. 10.1097\/PAS.0000000000001461","journal-title":"Am J Surg Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-01231-9","article-title":"Pan-cancer prevalence, risk, and clinical and demographic characteristics of Lynch syndrome-associated variants in BioBank Japan","volume":"5","author":"Mizukami K","year":"2025","unstructured":"Mizukami K, Usui Y, Iwasaki Y, et al.. Pan-cancer prevalence, risk, and clinical and demographic characteristics of Lynch syndrome-associated variants in BioBank Japan. Commun Med. 2025, 5:522. 10.1038\/s43856-025-01231-9","journal-title":"Commun Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s1368-7646(02)00047-x","article-title":"Molecular aspects of resistance to antitumor platinum drugs","volume":"5","author":"Brabec V","year":"2002","unstructured":"Brabec V, Kasparkova J. Molecular aspects of resistance to antitumor platinum drugs. Drug Resist Updat. 2002, 5:147-61. 10.1016\/s1368-7646(02)00047-x","journal-title":"Drug Resist Updat"},{"key":"ref13","article-title":"The role of DNA mismatch repair in platinum drug resistance","volume":"56","author":"Fink D","year":"1996","unstructured":"Fink D, Nebel S, Aebi S, et al.. The role of DNA mismatch repair in platinum drug resistance. Cancer Res. 1996, 56:4881-6.","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.12.7516","article-title":"Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor","volume":"174","author":"Lugade AA","year":"2005","unstructured":"Lugade AA, Moran JP, Gerber SA, Rose RC, Frelinger JG, Lord EM. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. J Immunol. 2005, 174:7516-23. 10.4049\/jimmunol.174.12.7516","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.06.020","article-title":"Radiation therapy to convert the tumor into an in situ vaccine","volume":"84","author":"Formenti SC","year":"2012","unstructured":"Formenti SC, Demaria S. Radiation therapy to convert the tumor into an in situ vaccine. Int J Radiat Oncol Biol Phys. 2012, 84:879-80. 10.1016\/j.ijrobp.2012.06.020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy004","article-title":"The heterogeneity between Lynch-associated and sporadic MMR deficiency in colorectal cancers","volume":"110","author":"Liu GC","year":"2018","unstructured":"Liu GC, Liu RY, Yan JP, et al.. The heterogeneity between Lynch-associated and sporadic MMR deficiency in colorectal cancers. J Natl Cancer Inst. 2018, 110:975-84. 10.1093\/jnci\/djy004","journal-title":"J Natl Cancer Inst"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051121","article-title":"Opportunities for conventional and in situ cancer vaccine strategies and combination with immunotherapy for gastrointestinal cancers, a review","volume":"12","author":"Bouzid R","year":"2020","unstructured":"Bouzid R, Peppelenbosch M, Buschow SI. Opportunities for conventional and in situ cancer vaccine strategies and combination with immunotherapy for gastrointestinal cancers, a review. Cancers. 2020, 12:1121. 10.3390\/cancers12051121","journal-title":"Cancers"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001446","article-title":"Role of adjuvant therapy in stage IIIC2 endometrial cancer","volume":"30","author":"Bogani G","year":"2020","unstructured":"Bogani G, Cappuccio S, Casarin J, et al.. Role of adjuvant therapy in stage IIIC2 endometrial cancer. Int J Gynecol Cancer. 2020, 30:1169-76. 10.1136\/ijgc-2020-001446","journal-title":"Int J Gynecol Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/path.5373","article-title":"Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas","volume":"250","author":"Le\u00f3n-Castillo A","year":"2020","unstructured":"Le\u00f3n-Castillo A, Gilvazquez E, Nout R, et al.. Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas. J Pathol. 2020, 250:312-22. 10.1002\/path.5373","journal-title":"J Pathol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S453337","article-title":"Assessment of immune status in patients with mismatch repair deficiency endometrial cancer","volume":"17","author":"Ma J","year":"2024","unstructured":"Ma J, Lin J, Lin X, et al.. Assessment of immune status in patients with mismatch repair deficiency endometrial cancer. J Inflamm Res. 2024, 17:2039-50. 10.2147\/JIR.S453337","journal-title":"J Inflamm Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/472702-complete-radiotherapy-response-of-chemoresistant-para-aortic-lymph-node-metastases-in-an-endometrial-cancer-patient-meeting-the-amsterdam-ii-criteria-for-lynch-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:22Z","timestamp":1776902422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/472702-complete-radiotherapy-response-of-chemoresistant-para-aortic-lymph-node-metastases-in-an-endometrial-cancer-patient-meeting-the-amsterdam-ii-criteria-for-lynch-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.107546","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,22]]}}}